Memorial Sloan-Kettering Cancer Center at Commack — Commack, New York

Memorial Sloan-Kettering Cancer Center at Commack is a clinical research site located in Commack, New York, United States 11725.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Memorial Sloan-Kettering Cancer Center at Commack has participated in 43 clinical trials with 8 currently active.

Therapeutic areas: Brain Cancer, Malignant Glioma, Recurrent Brain Metastases.

Sponsors: Memorial Sloan Kettering Cancer Center, Merck Sharp & Dohme LLC, Andrew B Lassman, MD.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Commack

Browse all research sites in New York · View every site in Commack

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan-Kettering Cancer Center at Commack?

Memorial Sloan-Kettering Cancer Center at Commack has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan-Kettering Cancer Center at Commack conducted?

Memorial Sloan-Kettering Cancer Center at Commack has 43 clinical trials on record, with 8 currently active. Their work covers Brain Cancer, Malignant Glioma, Recurrent Brain Metastases.

Is Memorial Sloan-Kettering Cancer Center at Commack accredited by Crixeo Clinical Trials?

Memorial Sloan-Kettering Cancer Center at Commack has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan-Kettering Cancer Center at Commack?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.